EUVIMEDEUVIMED entdecken
Crossref

Systematic total parietal peritonectomy for peritoneal mesothelioma-perioperative and oncological outcomes in an Indian cohort of 100 patients

Mufaddal Kazi, Avanish Saklani, Praveen Kammar, Ashwin Desouza, Vivek Sukumar, Viraj Lavingia, Sanket Mehta, Aditi Bhatt

European Journal of Surgical Oncology · 2026-09 · 52 (9) · 111978

DOI: 10.1016/j.ejso.2026.111978 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2026-09. Verfasst von Mufaddal Kazi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastrointestinal Surgical Oncology, Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, 400012, India; Department of Surgica…. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Cytoreduction Surgical Procedures, Mesothelioma, Peritoneum. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is the current standard of care for patients with peritoneal mesothelioma (PeM). In this retrospective study, we evaluate the perioperative and oncological outcomes of systematic total parietal peritonectomy (TPP) which has demonstrated a significant improvement in survival compared to selective parietal peritonectomy. METHODS: 100 patients with PeM treated by CRS-HIPEC from 1st January 2013 to 31st December 2022 at three high-volume peritoneal malignancy centers were included. All patients underwent TPP irrespective of the disease extent. A multivariable Cox-regression analysis was performed to identify prognostic factors for disease-free survival (DFS). RESULTS: Eighty-nine patients had malignant PeM (mPeM), with a median peritoneal cancer index (PCI) of 26 [IQR 20-35]. 77% had a CC0/CC1 resection. Twenty-six patients had a total small bowel mesenteric peritonectomy. 35.9% had resection of ≥1 bowel segments. The 90-day grade 3-4 morbidity was ___, and mortality 4.5%. The median overall survival (OS) and DFS were 70 months [95% confidence intervals (CI) 57- NR] and 23 months [95% CI-19-33], respectively. Ki67 > 9% (HR 9.63, p < 0.001), systemic chemotherapy use (HR 2.78, p = 0.007), and high-grade postoperative morbidity (HR 6.23, p < 0.001) were independent predictors of a poorer DFS. In 11 patients with well differentiated papillary mesothelioma, median DFS was 48 months (35-NR) and median OS 60 months (60-NR). CONCLUSION: The morbidity of TPP combined with multi-visceral resections was established. This multi-institutional study provides the first comprehensive data on PeM with oncological outcomes from India, serving as valuable baseline information from high-volume centers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal NeoplasmsCytoreduction Surgical ProceduresMesotheliomaPeritoneumMesothelioma, MalignantHumansFemaleMaleMiddle AgedRetrospective StudiesHyperthermic Intraperitoneal ChemotherapyIndiaAdultDisease-Free SurvivalSurvival RateAgedTreatment Outcome

Stichwörter der Autor:innen

Cytoreductive surgeryHyperthermic intraperitoneal chemotherapyPeritoneal mesotheliomaPrognostic factorsSurvivalTotal parietal peritonectomy

Autor:innen und Institutionen

  • Division of Gastrointestinal Surgical Oncology, Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, 400012, India; Department of Surgical Oncology, Advanced Centre for Treatment, Research, and Education in,…
  • Division of Gastrointestinal Surgical Oncology, Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, 400012, India; Dept of Surgical Oncology, Fortis Hospital, Mumbai, India.
  • Dept of Surgical Oncology, Special Surgical Oncology Hospital, Mumbai, India.
  • Dept of Medical Oncology, Shalby Cancer and Research Institute, Ahmedabad, India.
  • Dept of Surgical Oncology, Shalby Cancer and Research Institute, Ahmedabad, India.

Zitieren

APA

Kazi, M., Saklani, A., Kammar, P., Desouza, A., Sukumar, V., Lavingia, V., Mehta, S., & Bhatt, A. (2026). Systematic total parietal peritonectomy for peritoneal mesothelioma-perioperative and oncological outcomes in an Indian cohort of 100 patients. European Journal of Surgical Oncology, 52(9), 111978. https://doi.org/10.1016/j.ejso.2026.111978

Vancouver

Kazi M, Saklani A, Kammar P, Desouza A, Sukumar V, Lavingia V, et al. Systematic total parietal peritonectomy for peritoneal mesothelioma-perioperative and oncological outcomes in an Indian cohort of 100 patients. European Journal of Surgical Oncology. 2026;52(9):111978. doi:10.1016/j.ejso.2026.111978

BibTeX
@article{Kazi2026,
  author = {Kazi, Mufaddal and Saklani, Avanish and Kammar, Praveen and Desouza, Ashwin and Sukumar, Vivek and Lavingia, Viraj and Mehta, Sanket and Bhatt, Aditi},
  title = {Systematic total parietal peritonectomy for peritoneal mesothelioma-perioperative and oncological outcomes in an Indian cohort of 100 patients},
  journal = {European Journal of Surgical Oncology},
  year = {2026},
  volume = {52},
  number = {9},
  pages = {111978},
  doi = {10.1016/j.ejso.2026.111978}
}
Kostenlos starten →